A case of anti-MuSK antibody-positive myasthenia gravis with dropped head as the initial presenting symptom

Clinical Neurology

Volumn 46, Issue 7, 2006, Pages 496-500

  Okano, Tomoko ^a   Fujitake, Junko ^a   Suzuki, Kaori ^a,b   Mori, Nobuhito ^a   Sonobe, Masanobu ^a   Ohta, Kiyoe ^c   Nakane, Shunya ^d   Saida, Kyoko ^a  

^a KYOTO CITY HOSPITAL   (Japan)

^b TOTTORI PREFECTURAL CENTRAL HOSPITAL   (Japan)

^c UTANO NATIONAL HOSPITAL   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Anti MuSK antibody; Dropped head; Muscle specific tyrosine kinase; Myasthenia gravis; Seronegative MG

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR ANTIBODY; EDROPHONIUM; MUSCLE SPECIFIC TYROSINE KINASE ANTIBODY; PREDNISOLONE; PYRIDOSTIGMINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG WITHDRAWAL; FASCICULATION; FEMALE; HOSPITAL ADMISSION; HUMAN; MYASTHENIA GRAVIS; NEUROLOGIC EXAMINATION; TREATMENT OUTCOME;

AUTOANTIBODIES; FEMALE; HUMANS; MIDDLE AGED; MUSCLES; MYASTHENIA GRAVIS; NECK MUSCLES; PROTEIN-TYROSINE KINASES;

EID: 33750292513     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hoch W, McConville J, Helms S, et al: Auto-antibodies to the receptor tyrosine kinase MuSK in patents with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001; 7: 365-368
2. Patrick J, Lindstrom J: Autoimmune response to acetylcholine receptor. Science 1973; 180: 871-872
3. Drachman DB: Myasthenia gravis. N Engl J Med 1994; 330: 1797-1810
4. Vincent A, Palace J, Hilton-Jones D: Myasthenia gravis. Lancet 2001; 357: 2122-2128
5. Vincent A: Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol 2002; 2: 797-804
6. Glass DJ, Bowen DC, Stitt TN, et al: Agrin acts via a MuSK receptor complex. Cell 1996; 85: 513-523
7. Hopf C, Hoch W: Tyrosine phosphorylation of the muscle-specific kinase is exclusively induced by acetylcholine receptor-aggregating agrin fragments. Eur J Biochem 1998; 253: 382-389
8. Evoli A, Tonali PA, Padua L, et al: Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003; 126: 2304-2311
9. Sanders DB, El-Salem K, Massey JM, et al: Clinical aspects of MuSK antibody positive seronegative MG. Neurology 2003; 60: 1978-1980
10. Vincent A, Bowen J, Newsom-Davis J, et al: Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets. Lancet Neurol 2003; 2: 99-106
11. Vincent A, McConville J, Farrugia ME, et al: Antibodies in myasthenia gravis and related disorders. Ann NY Acad Sci 2003; 998: 324-335
12. Zhou L, McConville J, Chaudhry V, et al: Clinical comparison of muscle-specific tyrosine Kinase (MuSK) antibody-positive and -negative myasthenic patients. Muscle Nerve 2004; 30: 55-60
13. Nemoto Y, Kuwabara S, Misawa S, et al: Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis. J Neurol Neurosurg Psychiatry 2005; 76: 714-718
14. Stickler DE, Massey JM, Sanders DB: MuSK-antibody positive myasthenia gravis: clinical and electrodiagnostic patterns. Clin Neurophysiol 2005; 116: 2065-2068
15. Farrugia ME, Kennett RP, Newsom-Davis J, et al: Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis. Muscle Nerve 2006; 33: 568-570
16. Ishii W, Matsuda M, Okamoto N, et al: Myasthenia gravis with anti-MuSK antibody, showing progressive muscular atrophy without blepharoptosis. Inter Med 2005; 44: 671-672